Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Social Safety Learning in Social Anxiety Disorder
NCT05968651Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Social Anxiety Disorder (SAD), sponsored by University of Washington. Started Jun 2023; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05968651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05968651.